Recruiting Heart Attack Studies in Guangzhou
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question th...
Study of AZD9829 in CD123+ Hematological Malignancies
This is a modular, multicentre, open-label, Phase I/II, dose-setting study. AZD9829 will be administered intravenously as monotherapy or in combination in participants with CD123 positive hematologica...
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
This is a Phase 2a study to evaluate the safety and pharmacokinetics (PK) of luspatercept in pediatric participants with β-thalassemia. The study will be conducted in 2 parts for both transfusion-dep...
About Heart Attack Clinical Trials in Guangzhou
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 3 heart attack clinical trials recruiting participants in Guangzhou, GUANGDONG. These studies are seeking a combined 943 participants. Research is being sponsored by Corxel Pharmaceuticals, AstraZeneca, Celgene. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Guangzhou — FAQ
Are there heart attack clinical trials in Guangzhou?
Yes, there are 3 heart attack clinical trials currently recruiting in Guangzhou, GUANGDONG. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Guangzhou?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Guangzhou research site will contact you about next steps.
Are clinical trials in Guangzhou free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Guangzhou studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 3 active trials in Guangzhou are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov